Good Life Advisors LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 50.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,545 shares of the healthcare conglomerate’s stock after buying an additional 519 shares during the quarter. Good Life Advisors LLC’s holdings in UnitedHealth Group were worth $903,000 at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. Greater Midwest Financial Group LLC lifted its holdings in UnitedHealth Group by 0.8% during the 3rd quarter. Greater Midwest Financial Group LLC now owns 4,546 shares of the healthcare conglomerate’s stock valued at $2,658,000 after purchasing an additional 36 shares during the last quarter. Hengehold Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 25.5% during the 3rd quarter. Hengehold Capital Management LLC now owns 1,247 shares of the healthcare conglomerate’s stock worth $729,000 after buying an additional 253 shares during the period. Sensible Money LLC bought a new position in UnitedHealth Group in the 3rd quarter valued at about $210,000. Kowal Investment Group LLC boosted its holdings in shares of UnitedHealth Group by 27.3% during the third quarter. Kowal Investment Group LLC now owns 1,488 shares of the healthcare conglomerate’s stock worth $870,000 after acquiring an additional 319 shares during the period. Finally, SPC Financial Inc. lifted its holdings in UnitedHealth Group by 233.6% during the 3rd quarter. SPC Financial Inc. now owns 1,498 shares of the healthcare conglomerate’s stock worth $876,000 after purchasing an additional 1,049 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several research analysts have weighed in on the company. Royal Bank of Canada lowered their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday. Argus lifted their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Truist Financial reaffirmed a “buy” rating and set a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price objective for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Finally, UBS Group reduced their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday. Two analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $615.16.
UnitedHealth Group Stock Down 0.9 %
Shares of NYSE:UNH opened at $566.00 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $608.63. The company has a market capitalization of $522.66 billion, a PE ratio of 37.53, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. The company has a fifty day moving average of $584.20 and a 200-day moving average of $533.07.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period last year, the firm posted $6.56 earnings per share. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.68 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.48%. UnitedHealth Group’s dividend payout ratio is 55.70%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- How to Invest in Insurance Companies: A GuideĀ
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- What is a Stock Market Index and How Do You Use Them?
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.